Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of gamma-aminobutyric acid (GABA) modulators, which are important for treating anxiety, epilepsy, and insomnia. The trifluoromethyl group enhances metabolic stability and lipophilicity, improving drug penetration across the blood-brain barrier. It is also employed in the preparation of fluorinated analogs in medicinal chemistry to optimize pharmacokinetic properties.